Sodium Sulfacetamide 8% and Sulfur 4%

Akron Pharma Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 26, 2023
Approval ID: bfbe625c-5679-4363-913a-2ab03198f4f0
Products: 1 registered
Version: 3

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

Sodium Sulfacetamide 8% - Sulfur 4% Topical SuspensionIn a vehicle containing Green Tea and Aloe

Quick Stats

Total Products1

Labelers2

Label Sections12

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.